Skip to main content
Clinical Trials/NCT05004337
NCT05004337
Completed
Not Applicable

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies (VANISH)

Natera, Inc.21 sites in 1 country126 target enrollmentJuly 22, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vanishing Twin
Sponsor
Natera, Inc.
Enrollment
126
Locations
21
Primary Endpoint
The accuracy of the new algorithm to determine which of the signals in the Panorama samples correspond to the LT versus the DT.
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to collect blood samples from women carrying a vanishing twin pregnancy to further develop Natera's non-invasive prenatal screening test to provide information about possible chromosomal conditions for the living twin

Registry
clinicaltrials.gov
Start Date
July 22, 2021
End Date
November 29, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Women with either ultrasound-documented dizygotic (DZ) twin pregnancy or those whose Panorama Test™ results suggest increased risk for vanishing twin

Exclusion Criteria

  • Monozygotic twin pregnancy
  • Non twin pregnancy
  • Maternal history of bone marrow or organ transplantation

Outcomes

Primary Outcomes

The accuracy of the new algorithm to determine which of the signals in the Panorama samples correspond to the LT versus the DT.

Time Frame: 2 Years

Each complete participant in the study will have multiple maternal blood samples collected, and a child buccal swab. This outcome will use genetic analysis to reflect for each participant if the algorithm correctly or incorrectly identified the LT versus the DT. Accuracy, defined as the number of VT pairs correctly identified as the LT and DT, divided by the total number of VT pairs, will be calculated.

Develop a new algorithm and methodology that will measure fetal fraction and distinguish between the DT (demised/non-viable twin) and living twin (LT) in dizygotic twins (DZ) with a single LT.

Time Frame: 2 years

A new algorithm will be written to analyze the serial research blood samples to return a fetal fraction of each twin, and identify which twin is the DT verses the LT. The fetal fraction measurement will be a percentage, and it will be measurable, or not measurable for each sample.

Secondary Outcomes

  • The accuracy of the updated algorithm for the assignment of risk for trisomy 21/18/13 for the LT in DZ twins with a single LT.(3 Years)

Study Sites (21)

Loading locations...

Similar Trials